Home / Market News / $CLMB

$CLMB news and market catalysts

The 13 most recent market catalysts affecting $CLMB, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

13 catalysts 2 high impact 10 bullish 2 bearish Technology Distribution
Nov 19, 2026 Corporate Catalyst Bullish Impact 55
Climb Global Solutions Announces Distribution Agreement with Archer
Climb Global Solutions, through its subsidiary Climb, has entered into a distribution agreement with Archer, a GRC software provider. This partnership allows Climb to offer Archer'…
Nov 17, 2026 Corporate Catalyst Bullish Impact 55
Climb Channel Solutions Announces Strategic Partnership with Breach Secure Now
Climb Channel Solutions, a subsidiary of Climb Global Solutions, Inc., has entered into a strategic partnership with Breach Secure Now. This collaboration will see Breach Secure No…
Nov 9, 2026 Corporate Catalyst Bullish Impact 75
Analysts Upgrade Revenue and Earnings Forecasts for Climb Global Solutions
Analysts have raised their 2027 revenue projections for Climb Global Solutions to US$915 million, a 19% improvement, and increased EPS estimates by 40% to US$1.76. Concurrently, th…
Nov 5, 2026 Corporate Catalyst Bullish Impact 55
Wedbush Adjusts Price Target on Climb Bio to $27
Wedbush Securities has raised its price target for Climb Bio, Inc. from $25 to $27, maintaining an 'Outperform' rating. This analyst action is a direct result of Wedbush's ongoing …
Nov 5, 2026 Corporate Catalyst Neutral Impact 65
Climb Bio Reports Third Quarter 2026 Financial Results
Climb Bio's 8-K filing provides a mixed but generally positive update. The company's cash position of $227.6 million, expected to last into H2 2028, offers significant financial st…
Nov 4, 2026 Corporate Catalyst Bullish Impact 75
Freedom Capital Markets Raises Price Target on Climb Global Solutions to $50
Freedom Capital Markets, through analyst Almas Almaganbetov, has raised its price target for Climb Global Solutions (CLMB) to $50.00 from $32.50, while reiterating a Buy rating. Th…
Nov 2, 2026 Corporate Catalyst Bullish Impact 65
Barrington Research Raises Price Target on Climb Global Solutions to $47
Barrington Research raised its price target for Climb Global Solutions (CLMB) to $47 from $30, maintaining an 'Outperform' rating. This positive analyst action is attributed to the…
Oct 28, 2026 Corporate Catalyst Bullish Impact 85
Climb Global Solutions Reports Third Quarter 2026 Financial Results
Climb Global Solutions reported record net sales and gross billings for the third quarter of 2026, indicating robust growth and strong demand for its IT distribution solutions. Thi…
Oct 25, 2026 Corporate Catalyst Bullish Impact 75
Climb Bio Presents Initial PrisMN Phase 2 Data for Budoprutug at ASN Kidney Week 2026
Climb Bio presented initial Phase 2 data for its drug budoprutug at ASN Kidney Week 2026, showing promising results in B-cell depletion and immunologic remission for kidney disease…
Oct 23, 2026 Corporate Catalyst Bearish Impact 75
Climb Bio and Mabworks Announce CLYM116/MIL116 Data at ASN Kidney Week 2026
Climb Bio and Mabworks released new data for CLYM116/MIL116 at ASN Kidney Week 2026, showing over 90% free APRIL suppression sustained for 12 weeks and a 70% reduction in Gd-IgA1. …
Aug 14, 2026 Corporate Catalyst Bullish Impact 75
Climb Bio shares are trading higher after Beijing Mabworks Biotech announced the dosing of the first patient in a Phase 2 trial for immunoglobulin A nephropathy in China, conducted in collaboration with Climb Bio.
This headline represents a significant corporate catalyst for Climb Bio, as the initiation of a Phase 2 trial is a critical milestone in drug development. Successful progression th…
Aug 5, 2026 Corporate Catalyst Bullish Impact 65
Climb Global Solutions Announces US Distribution Agreement With Harmonic Security For AI Governance Platform Across Its VAR And MSP Network
This distribution agreement is a positive development for Climb Global Solutions, as it diversifies their product offerings into the high-growth AI governance market. For Harmonic …
Jul 29, 2026 Corporate Catalyst Bearish Impact 92
Climb Global Solutions Q2 Adj. EPS $0.30 Misses $0.31 Estimate, Sales $174.209M Miss $174.971M Estimate
Climb Global Solutions (CLMB) reported Q2 earnings that fell short of analyst expectations on both the top and bottom lines. The adjusted EPS of $0.30 missed the $0.31 estimate, an…
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.